BiotechTube

riboflavin solution + placebo solution

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Keratoconus

Conditions

Keratoconus

Trial Timeline

Jul 1, 2012 → Sep 1, 2016

NCT ID
NCT01643226

About riboflavin solution + placebo solution

riboflavin solution + placebo solution is a phase 3 stage product being developed by Glaukos for Keratoconus. The current trial status is completed. This product is registered under clinical trial identifier NCT01643226. Target conditions include Keratoconus.

What happened to similar drugs?

2 of 6 similar drugs in Keratoconus were approved

Approved (2) Terminated (1) Active (3)
🔄riboflavin solution + placebo solutionGlaukosPhase 3
🔄riboflavin ophthalmic solutionGlaukosPhase 3
❌riboflavin solution + placebo solutionGlaukosPhase 3
✅Riboflavin 5'-PhosphateGlaukosApproved
🔄Test Article A + Test Article B + PlaceboGlaukosPhase 3
✅Dextenza + Prednisolone AcetateOcular TherapeutixApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT01972854Phase 3Terminated
NCT01344187Phase 3Completed
NCT01643226Phase 3Completed

Competing Products

7 competing products in Keratoconus

See all competitors
ProductCompanyStageHype Score
riboflavin solution + placebo solutionGlaukosPhase 3
37
riboflavin ophthalmic solutionGlaukosPhase 3
37
GLK-221 Ophthalmic Solution + Placebo Ophthalmic SolutionGlaukosPhase 2
39
riboflavin solution + placebo solutionGlaukosPhase 3
29
Riboflavin 5'-PhosphateGlaukosApproved
40
Test Article A + Test Article B + PlaceboGlaukosPhase 3
37
Dextenza + Prednisolone AcetateOcular TherapeutixApproved
37